BI-771716
- Generic Name
- BI-771716
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
Phase 2
Recruiting
- Conditions
- Macular Degeneration, Age-relatedGeographic Atrophy
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 180
- Registration Number
- NCT06722157
- Locations
- 🇺🇸
Associated Retina Consultants, Gilbert, Arizona, United States
🇺🇸Associated Retina Consultants, Ltd., Phoenix, Arizona, United States
🇺🇸Phoenix Retina Associates, Phoenix, Arizona, United States
A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 20
- Registration Number
- NCT06006585
- Locations
- 🇺🇸
Retina Consultants of Houston, PA-Houston-62050, Houston, Texas, United States
🇺🇸Retina Consultants of Texas-The Woodlands-67575, The Woodlands, Texas, United States
🇺🇸Bay Area Retina Associates - Walnut Creek, Walnut Creek, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath